T-Knife GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.t-knife.com
Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase 1/ 2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/ Metastatic MAGE-A1+ Solid Tumors
Phase 1
Terminated
- Conditions
- Advanced Solid Tumors
- First Posted Date
- 2022-06-24
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- T-knife GmbH
- Target Recruit Count
- 23
- Registration Number
- NCT05430555
- Locations
- 🇧🇪
Universite Catholique de Louvain (UCL) - Cliniques Universitaires Saint-Luc - Institut Roi Albert II, Brussels, Belgium
🇧🇪Universite Libre de Bruxelles (ULB) - Institut Jules Bordet Anderlecht, Brussel, Belgium
🇧🇪University Hospital Ghent, Ghent, Belgium
News
No news found